Healthcare Industry Trends and Updates

Growing consumer awareness, rising focus on dental aesthetics, expanding middle-class population with increasing disposable incomes in developing nations, and rising dental tourism in emerging markets are the major factors driving the growth of the cosmetic dentistry market. With rising focus on technological innovations and the increasing trend of R&D investments, various new products such as dental implants and equipment are being launched in Cosmetic Dentistry Market , which are expected to further propel market growth. However, a lack of reimbursements for cosmetic dental procedures and the high cost of dental imaging systems could restrain the growth of this market during the forecast period. Download FREE Illustrative Helpful Overview of the Report: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=3096361 Cosmetic Dentistry market is segmented into dental implants, dental bridges, dental crowns, dental veneers, dental systems and equipment, orthodontic braces, bonding

A number of factors, such as the growing demand for long-term pain management among the geriatric population, large patient population base, adverse effects of pain medications, development of novel pain management device, established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries, and high proven efficacy of pain management device for the treatment of chronic pain are driving the growth of the global market. The Asia-Pacific region has become an attractive destination for companies engaged in the manufacture of pain management device. The high growth opportunities in this regional segment can be attributed to a number of factors, including growing incidence of chronic diseases, improving healthcare infrastructure in the region, growing middle-class population and disposable income levels, and rising awareness about the safety and efficacy of pain management device. The global pain management devices market is valued at an estimated USD 3.08 B

The 3D cell culture market is expected to reach USD 1,720.3 Million by 2022 from USD 682.8 Million in 2017, at a CAGR of 20.3%. Factors such as the rising focus on developing alternative methods for animal testing, funding initiatives from government and private investors, technological advancements and product launches, and growing awareness are driving the growth of this market. Agreements, partnerships, and collaborations accounted for the largest share of the overall growth strategies followed by key players between 2014 and 2017. Some of the companies that adopted this strategy include Mimetas (Netherlands), Emulate (US), and Lonza (Switzerland). Download Free Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191072847 The 3D cell culture market is highly competitive with several big and small players. Prominent players in this market include Thermo Fisher (US), Corning (US), Lonza (Switzerland), Merck (Germany), ReproCELL (Japan), and InSphero (Switzerland). Th

The growth in epigenetics market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. Growing applications in Personalized Medicine and Targeted Therapy in Oncology is a growth opportunity for the Epigenetics Market According to a press release published by the Tufts Center for the Study of Drug Development in May 2015, biopharmaceutical companies have nearly doubled their R&D investments in personalized medicine over the last five years, and these investments are further expected to increase by 33% over the next five years. This will further drive the use of epigenetics tools. A 2016 study performed t

The U.S. insomnia market is categorised into pharmacological treatments and non-pharmacological treatments. The U.S. insomnia pharmacological treatment market is projected to reach USD 4.24 Billion by 2021 from USD 3.38 Billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021. The duration of insomnia can be from a day to years. Based on duration, insomnia is divided into three major categories, namely, transient insomnia (less than a month), short term insomnia (between 1 month and 6 months), and chronic insomnia (more than 6 months). The non-pharmacological treatment market is categorized into cognitive behavioural therapy for insomnia (CBTI), hypnotherapy, and other alternative therapies. CBTI is highly recommended therapy for insomnia patients followed by hypnotherapy due as its can be used with multiple approaches that enables physicians to understand and cure patients comprehensibly. The other alternative therapies includes exercise/yoga, acupuncture, biofeedback, bright lig

The global top 10 medical device technologies market is expected to reach USD 428.97 Billion by 2020, at a CAGR of 5.5% from 2015 to 2020. Growth in the global top 10 medical device technologies market is mainly driven by factors such as the rising prevalence of chronic diseases and related increase in disability-adjusted life years (DALYs), technological advancements in medical devices, and growing aging population. Moreover, increasing investments from government bodies and private players in healthcare sectors in emerging economies and increasing focus of key players on emerging countries are creating new growth opportunities for this market. However, uncertainty in reimbursement and excise tax on medical devices in the U.S. are restraining the growth of the market. The top 10 medical device technologies market studied in this report is mainly segmented by types and region. Based on type, the top 10 medical device technologies market is segmented into in vitro diagnostics (IV